Coya Therapeutics
COYA
15 hedge funds and large institutions have $5.45M invested in Coya Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
7% more funds holding
Funds holding: 14 → 15 (+1)
0.65% more ownership
Funds ownership: 13.59% → 14.24% (+0.65%)
1% less capital invested
Capital invested by funds: $5.5M → $5.45M (-$52.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Greenlight Capital
New York
|
+$300K |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
+$159K |
| 3 |
PCM
Prelude Capital Management
New York
|
+$142K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$113K |
| 5 |
BlackRock
New York
|
+$58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$203K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$187K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$108K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$49.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$42.9K |
COYA Hedge Fund Activity: Q3 2023 in Review
15 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q3 2023, worth a combined $5.45M — down 0.95% from $5.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new COYA positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Greenlight Capital, adding an estimated $300K. The largest seller was AIGH Capital Management, cutting an estimated $203K.
- 15 institutional investors held Coya Therapeutics (COYA) as of Q3 2023, up from 14 in Q2 2023.
- Funds reported $5.45M of Coya Therapeutics stock for Q3 2023, down 0.95% quarter-over-quarter.
- 4 funds opened new Coya Therapeutics positions in Q3 2023 and 3 closed out, a net change of +1 holder.
- The largest Coya Therapeutics buyer in Q3 2023 was Greenlight Capital, an estimated $300K added.
- The largest Coya Therapeutics seller in Q3 2023 was AIGH Capital Management, an estimated $203K sold.
Based on aggregated 13F filings for Q3 2023.